The Metabolic Imaging group aims at developing robust and highly sensitive metabolic imaging methods at ultra-high field for application in clinical studies on cancer, brain disorders, metabolic disorders, cardiovascular disease and muscle (patho)physiology.
The MRS-group develops 1H, 2H, 31P, 13C, 19F and 23Na metabolic imaging methods in the brain and body for use at ultra-high field (7 Tesla) MR systems.
- Jannie Wijnen (scientific manager)
Robust and fast metabolic imaging methods for pediatric metabolic disorders and brain tumors.
- Jeanine Prompers (scientific director)
MR imaging and spectroscopy of metabolism and mitochondrial function in metabolic disorders.
- Alex Bhogal
Functional metabolic imaging of cerebral physiology in brain disorders